Literature DB >> 20487238

An ex vivo multi-electrode approach to evaluate endogenous hormones and receptor subtype pharmacology on evoked and spontaneous neuronal activity within the ventromedial hypothalamus; translation from female receptivity.

Clair Booth1, Christopher P Wayman, Vivienne Margaret Jackson.   

Abstract

INTRODUCTION: The ventromedial hypothalamus (VMH) controls female rodent copulatory behavior, which can be modulated by injection of various compounds into the VMH. Aim. The aim was to determine whether evoked excitatory postsynaptic potentials (EPSPs) or single-unit activity within the VMH ex vivo is a better parameter to predict lordosis.
METHODS: VMH slices were placed onto a 64 microelectrode chip and spontaneous single-unit activity was recorded or slices stimulated to evoke EPSPs. MAIN OUTCOME MEASURES: The sodium channel blocker, tetrodotoxin and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate antagonist, 6,7-dinitroquinoxaline-2,3-dione (DNQX) inhibited EPSPs, confirming EPSPs were glutamatergic in origin. The GABA(A) antagonist bicuculline potentiated EPSPs implying endogenous GABA tone. Single-unit activity was abolished by tetrodotoxin but unaffected by DNQX or bicuculline.
RESULTS: Glutamatergic neurotransmission was greatest during metestrous and following ovariectomization. The number of regions within the VMH eliciting single-unit activity was reduced following ovariectomy without changing spike frequency. Adrenergic agents increasing lordosis via the VMH in vivo, decreased glutamate neurotransmission but increased single-unit activity. Conversely, agents decreasing lordosis via the VMH increased glutamatergic neurotransmission and inhibited single-unit activity (8-OH-DPAT, [D-Ala(2), N-Me-Phe(4), Gly-ol(5)]-enkephalin, corticotropin releasing factor, bicuculline). Melanocortin and pituitary adenylate cyclase-activating polypeptide agonists had no effect.
CONCLUSIONS: Here we present a novel, robust VMH in vitro technique that (i) is consistent with the hypothesis that glutamate via non-NMDA receptors inhibits lordosis; (ii) glutamate is under the endogenous tone of GABA and steroid hormones; (iii) inhibition of lordosis during metestrous and following ovariectomy potentiates glutamatergic neurotransmission; (iv) activation of G(q)- and G(i)-coupled receptors decreases and increases glutamate neurotransmission, respectively, with an inverse correlation on single-unit activity; (v) activation of G(s)-coupled receptors has no direct effect on glutamate or single-unit activity; and (vi) potency, receptor subtypes and localization can be determined prior to in vivo studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20487238     DOI: 10.1111/j.1743-6109.2010.01843.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  4 in total

Review 1.  Ovarian hormone action in the hypothalamic ventromedial nucleus: remodelling to regulate reproduction.

Authors:  G D Griffin; L M Flanagan-Cato
Journal:  J Neuroendocrinol       Date:  2011-06       Impact factor: 3.627

2.  The Impact of Oxytocin Gene Knockout on Sexual Behavior and Gene Expression Related to Neuroendocrine Systems in the Brain of Female Mice.

Authors:  Josi Maria Zimmermann-Peruzatto; Virgínia Meneghini Lazzari; Grasiela Agnes; Roberta Oriques Becker; Ana Carolina de Moura; Renata Padilha Guedes; Aldo Bolten Lucion; Silvana Almeida; Márcia Giovenardi
Journal:  Cell Mol Neurobiol       Date:  2016-08-24       Impact factor: 5.046

Review 3.  Oxytocin and dendrite remodeling in the hypothalamus.

Authors:  Sarah L Ferri; Loretta M Flanagan-Cato
Journal:  Horm Behav       Date:  2012-01-28       Impact factor: 3.587

4.  Changes in neuronal activity across the mouse ventromedial nucleus of the hypothalamus in response to low glucose: Evaluation using an extracellular multi-electrode array approach.

Authors:  Lydia Hanna; Tristan J Kawalek; Craig Beall; Kate L J Ellacott
Journal:  J Neuroendocrinol       Date:  2020-02-23       Impact factor: 3.627

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.